Keloids are a fibroproliferative disease due to abnormal wound healing process after skin injury. They are characterized by over-production of extracellular matrix (ECM) such as collagens. MicroRNAs (miRNAs) are non-coding small RNAs and negatively regulate protein expression. Several miRNAs that play critical roles in tissue fibrosis and ECM metabolism have been reported. However, regulation and function of miRNAs in keloid remain to be explored. The purpose of the present study was to identify miRNAs involved in keloid pathogenesis. We performed miRNA microarray analysis to compare miRNA expression profiles between keloid-derived fibroblasts (KF) and normal fibroblasts (NF).
Introduction
Keloids are a benign dermal fibroproliferative disease due to abnormal wound healing process after skin injury. They are characterized by over-production of extracellular matrix (ECM) and invasiveness beyond the original boundary of the insult. Excess deposition of ECM such as collagen (Niessen et al., 1999; Syed et al., 2011) by fibroblasts is responsible for keloid, but its etiology and mechanism are still poorly understood. Although keloid is a benign dermal tumor, its management is one of the most challenging clinical problems.
Keloids do not regress with time, and surgical excision alone results in a high rate of recurrence. Various conservative therapies have been attempted, but definite and effective treatment has not been established yet (Al-Attar et al., 2006; Seifert and Mrowietz, 2009 ).
MicroRNAs (miRNAs) are non-coding and single-stranded small RNAs that negatively regulate gene expression. Mature miRNA is approximately 22 nucleotides in length; it binds to target messenger RNA (mRNA) and induces its cleavage or translational repression depending on the degree of complementarity (Bartel, 2004) . miRNAs play critical roles in many important biological processes, such as cell growth, proliferation, differentiation and apoptosis (Esquela-Kerscher and Slack, 2006) . To date, hundreds of miRNAs have been identified to be dysregulated in various diseased tissues (Lu et al., 2008) , but only a fraction of them has been functionally characterized.
Recently, some miRNAs have been reported to participate in fibrosis and ECM metabolism (Chau and Brenner, 2011; Jiang et al., 2010) . The miR-29 family members (miR-29a, miR-29b, miR-29c) directly regulate translation of various ECM mRNAs, such as collagen superfamily (Chau and Brenner, 2011; Jiang et al., 2010) . They are also implicated in fibroblasts in cardiac fibrosis (van Rooij et al., 2008) , stellate cells in hepatic fibrosis 5 (Ogawa et al., 2010; Roderburg et al., 2011) and dermal fibroblasts in systemic sclerosis (Maurer et al., 2010) . miR-21 expression is increased selectively in fibroblasts in failing heart and controls interstitial fibrosis and cardiac hypertrophy (Thum et al., 2008) .
As a novel therapeutic approach for fibrotic disorders, several miRNA gene therapies have been attempted. In particular, antagonizing endogenously upregulated miRNA using antisense strand has been proposed (Brown and Naldini, 2009) . Van Rooij et al. showed that inhibiting miR-29 using cholesterol-conjugated antisense strand increased collagen expression in mice liver, kidney and heart (van Rooij et al., 2008) . Another group reported that inhibition of miR-21 prevented interstitial fibrosis and cardiac hypertrophy in a mouse model of heart infarction (Thum et al., 2011) .
Thus, miRNAs play a number of roles in fibrosis and have attracted attention as a novel target for gene therapy. However, regulation and function of miRNAs in keloid tissues remain unknown. In the present study, we performed a comprehensive analysis of miRNA expression in keloid-derived fibroblasts (KF) and normal fibroblasts (NF) using miRNA microarray and then explored the function of miR-196a, which showed the highest fold-change in KF compared with NF.
Results and Discussion

Expression profile of miRNAs in KF
To identify miRNAs specifically regulated in KF, we first performed a comprehensive analysis of miRNA expression in KF and NF using miRNA expression microarrays. Each three samples of KF and NF were examined for changes in miRNA expression (Table 1) .
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Twenty seven miRNAs were identified to be differentially expressed in KF compared with NF (unpaired t-test, p<0.05): seven miRNAs were overexpressed, and 20 were underexpressed (Table 2) . Among these miRNAs, miRNA-142-3p and miR-196a showed the highest fold-change (miR-142-3p: 9.856-fold and miR-196a: 0.093-fold in KF compared with NF). Then we focused on these two miRNAs in the following analysis.
Comparative analysis of the miRNA expression at passage 0 and 2
Change of gene expressions and growth factor kinetics due to passage and/or long time culture have become an important problem in in vitro research using primary fibroblasts (Hirth et al., 2002; Yuan et al., 1996) . Therefore, we first compared the expression of those miRNAs in primary fibroblasts at passage 0 with that at passage 2 by TaqMan real-time RT-PCR assay. Surprisingly, the apparent difference in miR-142-3p expression at passage 0 was completely lost at passage 2 ( Figure 1a ). By contrast, the difference in miR-196a tended to be expanded after passage 2 (Figure 1b ). These data suggest that miRNA expression could be rapidly altered during early passages. In general, primary fibroblasts with low passage number are used to compare gene expression to avoid loss of characteristics (Feghali and Wright, 1999; Seifert et al., 2008; Smith et al., 2008) . It has been reported that collagen gene expression changed gradually during passage 0-3 in primary KF (Syed et al., 2011) . Similarly, the expression pattern of integrin collagen receptors changed in KF at successive passages 0-4 (Szulgit et al., 2002) . Likewise, the effect of passage and milieu alteration may affect miRNA expression in KF. According to our results (Figure 1 ), the degree of change seems to be dependent on each individual miRNA, suggesting that careful analysis is required in experiment to measure a miRNA expression level in primary KF. Hence, KF and NF at passage 0 were used in the following experiments.
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Validation of the miRNA expression by real-time RT-PCR
To validate the microarray data, we also performed the TaqMan real-time RT-PCR assay for miR-142-3p and miR-196a in KF and NF using nine samples each (Table 1) . As shown in Figure 2 , miR-142-3p was overexpressed ( Figure 2a ) and miR-196a was underexpressed (Figure 2b ) in KF compared with NF, and these differences were statistically significant. Of nine keloid samples, KF1 and KF4 were obtained from different sites, chest and shoulder, in a same patient. Six were caused by minor wounds such as acne and scratch, and three were by surgical operations: lung cancer, coronary artery bypass grafting and recurrence of keloid resected 20 years ago (Table 1) . Six cases had previous treatments such as topical corticosteroid and oral administration of Tranilast, but they were ineffective (Table 1) .
There seems to be no correlation between the miRNA expression level and clinical features.
These data indicate that we successfully confirmed the differential expressions of miR-142-3p and miR-196a in KF and NF.
In silico identification of possible target genes
To explore the mechanisms by which these miRNAs contribute to keloid pathogenesis, three web-based databases, miRanda (Betel et al., 2008) , TargetScan (Lewis et al., 2005) and PicTar (Krek et al., 2005) were used to search for possible target mRNAs of these miRNAs. Regarding targets of miR142-3p, 2,634 genes in miRanda, 250 genes in TargetScan and 200 genes in PicTar were predicted. Among the three databases, 70 genes were commonly shared ( Figure S1 ) and are listed in Table S1 . Correspondingly, 47 genes were shared as targets of miR-196a (Table S2) : 2,783 genes in miRanda, 180 genes in TargetScan and 162 genes in PicTar ( Figure S1 ).
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Collagen genes as a target of miR-196a miRNAs were initially proposed to mediate translational repression of their target mRNAs.
However, it has been recently demonstrated that this is often accompanied by decrease in mRNA abundance itself (Baek et al., 2008; Selbach et al., 2008) . We therefore searched for target genes of miR-142-3p using real-time RT-PCR for mRNA; among the candidate genes, we examined ADCY9, BCLAF1, CFL2, COL24A1, HMGA2 and ROCK2, which are implicated in collagen synthesis, apoptosis, actin filaments, collagen, TGFβ signaling and Rho-actin signaling, respectively. Unfortunately, we did not identify reproducible differences in any of these candidates between nine KF and nine NF samples (data not shown). Presumably, these genes are regulated by a number of different pathways, and miR-142-3p is probably not a major effector in dermal fibroblasts.
Among the predicted target genes of miR-196a, we focused on collagens (COL1A1, COL1A2, COL3A1), because one of the major findings in keloid pathology is increased ECM deposition, and collagen family is a dominant component of ECM (Al-Attar et al., 2006) . The expression of some of collagen mRNAs is increased in KF (Shih and Bayat, 2010) , and type I and III collagen proteins are increased in keloid (Ala-Kokko et al., 1987; Syed et al., 2011 ). We confirmed the increased level of COL1A1, COL1A2 and COL3A1 mRNAs in our samples ( Figure S2 ). Indeed, COL1A1, COL1A2 and COL3A1 have potential miR-196a target site in their 3'UTR, and the complementarity between the target sites and the miR-196a seed region (2-8 nucleotides of the 5'-end of miR-196a) is completely matched ( Figure S3 ). The complementarity between the seed region of miRNA and 3'UTR of mRNAs is the most important determinant for target specificity (Bartel, 2009) , and miRNA-mediated translational repression often depends on perfect or near-perfect base pairing of a seed region to its target (Doench and Sharp, 2004) . Therefore, type I and III collagens are strong candidates that are regulated by miR-196a.
Effect of miR-196a on the expression of collagens
To determine the biological function of miR-196a, we used predesigned and functionally tested Pre-miR TM miRNA Precursor Molecule (Pre-miR-196a) and Anti-miR TM miRNA
Inhibitor (Anti-miR-196a) to overexpress and knockdown miR-196a, respectively. We first assessed transfection efficiency using FAM-labeled Pre-miR TM and Anti-miR TM Scrambled
Negative Control (Scrambled) with a fluorescence microscope, and it was almost 100% in our hands (data not shown). We also confirmed a robust increase of the miR-196a level 
Luciferase reporter assay
To further investigate whether miR-196a directly regulates the expression of type I and III collagens, we generated luciferase reporter plasmids containing the 3'UTR of the COL1A1 or COL3A1 gene (pmirGLO-COL1A1-3'UTR and pmirGLO-COL3A1-3'UTR). First, we transfected these plasmids into NF and KF and measured luciferase activity. As shown in Figure 3c , the luciferase activity in KF was significantly higher than that in NF. It may reflect the difference of the miR-196a expression between KF and NF. Next, NF were transfected wtih the reporter plasmids together with Pre-miR-196a or Anti-miR-196a. As shown in Figure 3d , cotransfection with Pre-miR-196a reduced both luciferase activities driven from the reporter plasmids carrying the COL1A1 and COL3A1 3'UTR. Moreover, Anti-miR-196a increased the luciferase activities as compared with the scramble ( Figure   3e ). These findings suggest that miR-196a directly regulates the expression of collagen I
and III through targeting the 3'UTRs of the COL1A1 and COL3A1 genes in fibroblasts.
CpG island methylation of the miR-196a promoters.
It has been recently reported that some of disease-associated miRNAs are silenced by aberrant DNA methylation of their promoter CpG island (Bandres et al., 2009; Kozaki et al., 2008; Lujambio et al., 2007; Tsai et al., 2010) . To determine whether promoter methylation is responsible for miR-196a underexpression in KF, we used a methylation-specific PCR method. Mature miR-196a derives from two pri-miRNAs:
pri-miR-196a-1 (genomic region, chr17:46709852-46709921) and pri-miR-196a-2 (genomic region, chr12:54385522-54385631); genomic regions are based on the NCBI database (http://www.ncbi.nlm.nih.gov/). We then examined both promoter regions of these two pri-miRNAs. As previous studies have indicated that most human miRNA promoters are located around -1,000 bp upstream of mature miRNA (Saini et al., 2008; Zhou et al., 2007) , primers designed within CpG island that are located on the putative promoter region were used (Hoffman et al., 2009; Suzuki et al., 2011) . As shown in Figure 4a , unmethylated promoters were dominant for pri-miR-196a-1. On the other hand, methylation was remarkable for pri-miR-196a-2 ( Figure 4b ). However, there were no differences in the level of methylation status between KF and NF in both loci ( Figure 4a and 4b). These data suggest that downregulation of the miR-196a expression in KF is not due to epigenetic regulation by aberrant methylation of their promoter regions. Other upstream unknown factors may be involved in this regulation.
In summary, the expression profiles of miRNA between KF and NF were apparently distinct. Since it has been demonstrated that each individual miRNA could have hundreds of mRNA targets, miRNAs that are differentially regulated in KF may play a variety of roles in keloid pathogenesis. miR-196a displayed the highest altered expression in KF compared with NF and regulated the expression of type I and III collagens, whose deposition is a major manifestation in keloid pathology. The mechanisms of the reduced expression of miRNA-196a still remain to be elucidated; however, miR-196a could be an attractive therapeutic target, since there have been attempts trying topical administration of RNA-based drugs (Bak and Mikkelsen, 2010; Ritprajak et al., 2008; Takanashi et al., 2009 ).
Materials and Methods
Tissue samples
Nine keloid tissue samples were obtained from eight different Japanese patients at the time of surgery, and diagnosis was confirmed by routine pathological examination. Normal skin tissue samples were obtained from nine different Japanese volunteers. All experiments were performed after obtaining approval of the ethical committee of Nagasaki University
Hospital and adhered to the Helsinki Guidelines. Written informed consent was obtained from each individual. The sample profiles are summarized in Table 1 .
Cell culture
Primary culture of dermal fibroblasts were established as previously described (Arakawa et al., 1990) . Explants were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% (w/v) penicillin/streptomycin in 5% CO₂ humidified atmosphere at 37°C. Fibroblast obtained at the first culture for two weeks (at passage 0) were used in this study, except as indicated otherwise.
miRNA microarray
Total RNAs were extracted from KF and NF using a miRNeasy mini kit (QIAGEN, Tokyo, Japan) according to the manufacturer's instruction. Five hundred nanograms of the total RNAs were subjected to an Agilent miRNA microarray analysis service (Hokkaido System Science, Sapporo, Japan). Data analysis was done with GeneSpring GX software (Agilent Technology Japan, Tokyo, Japan). The array contained probes for 866 human and 89 viral miRNAs. Probes with "present call" flag in at least one sample in both groups were used for further data analyses (27 probes). Differences between groups were examined for statistical significance with unpaired t-test. p-value not exceeding 0.05 was considered statistically significant.
Real-time RT-PCR for miRNA
The quantitative real-time RT-PCR for miRNA was performed using TaqMan MicroRNA Assays (Applied Biosystems, Life Technologies Japan, Tokyo, Japan). Briefly, 10 ng of total RNA were reverse transcribed using a specific looped RT primer for each miRNA using a corresponding TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems).
The following amplification was performed using a corresponding TaqMan MicroRNA Assay Mix, TaqMan Universal PCR Master Mix and No AmpErase UNG (Applied Biosystems) in a Thermal Cycler Dice Real-time system (TaKaRa Bio, Ohtsu, Japan).
RNU6B was used as an internal control. The cycle threshold value, which was determined 13 using second derivative, was used to calculate the normalized expression of the indicated miRNAs using Q-Gene software (Muller et al., 2002) .
Real-time RT-PCR for mRNA
Total RNA was extracted using ISOGEN reagent (NIPPON GENE, Tokyo, Japan)
according to the manufacturer's instruction. One microgram of total RNA was reverse transcribed using a High capacity RNA-to-cDNA kit (Applied Biosystems). GTAACCCGTTGAACCCCATT and anti-sense, CCATCCAATCGGTAGTAGCG.
Western blot
To obtain secreted ECM proteins, culture media were collected and filtered with a 0.22 µm filter (MillexGV, Millipore, Bedford, MA). Protein concentration was determined with a Bichinonic Acid Assay kit (Sigma-Aldrich Japan, Tokyo, Japan). Equal amount of proteins (15 µg) were mixed in sample buffer containing 0.125 M Tris-HCl (pH6.8), 30% Glycerol, 35 μM sodium dodecyl sulfate, 60 μM dithiothreitol and bromphenol blue. After heated for 3 min at 99°C, the proteins were resolved by SDS-PAGE and transferred onto polyvinylidene difluoride membrane (Millipore) by semidry blotting. After incubation with appropriate primary antibody, the antigen-antibody complex was visualized using 14 horseradish peroxidase (HRP)-conjugated secondary antibody and the Chemi-Lumi One system (Nacalai Tesque, Kyoto, Japan). To enhance sensitivity, Can Get Signal reagent (TOYOBO, Osaka, Japan) was used. Detection was performed using a LAS3000 imaging system (FUJI film, Tokyo, Japan). Antibodies were obtained from the following sources:
anti-fibronectin polyclonal from Santa Cruz Biotechnology (Santa Cruz, CA); anti-collagen type I polyclonal and anti-collagen type III polyclonal from Rockland Immunochemicals (Gilbertsville, PA); HRP-conjugated secondary anti-rabbit/mouse IgG from Cell Signaling Technology (Beverly, MA).
Transfection of Pre-miR/Anti-miR-196a
Cells were transfected with Pre-miR TM miRNA Precursor Molecule for miR-196a Negative Control #1 using Lipofectamine 2000 (Invitorogen, Life Technologies Japan, Tokyo, Japan) at the final concentration of 50 nM. All the above functional molecules were purchased from Applied Biosystems. Transfection efficiency was assessed using a fluorescence microscopy DM6000B (Leica Microsystems, Tokyo, Japan).
Luciferase reporter assay
The 3'UTRs containing the putative miRNA target regions of the COL1A1 and COL3A1 genes were amplified by PCR using fibroblast genomic DNA as a template. 
Methylation-specific PCR
DNA methylation patterns in the promoter region of the miR-196a-1 and miR-196a-2 genes were analyzed by methylation-specific PCR as previously described with minor modifications (Esteller et al., 1999; Umetani et al., 2005) . Briefly, genomic DNA was isolated from cells using a QIAamp DNA Mini kit (QIAGEN). Bisulfite conversion was then carried out using an EpiTect Bisulfite kit (QIAGEN). Following PCR was done using ExTaq HS (TaKaRa Bio). The primer sequences are as described previously: for miR-196a-1 (Suzuki et al., 2011) and for miR-196a-2 (Hoffman et al., 2009 
Statistical analysis
Difference between two related groups was examined for statistical significance with paired t-test, and two independent groups were examined with Mann-Whitney test. For more than two groups, one-way ANOVA followed by Tukey's post test was used. P-value not exceeding 0.05 was considered statistically significant. Data were analyzed with PRISM version 4 software (GraphPad Software, La Jolla, CA).
Conflict of Interest
The authors state no conflict of interest. 
